Clinically, a dysregulated Sirt1 level and its activity have been found in the livers of patients with extrahepatic cholestasis and nonalcoholic fatty liver disease [21,56]. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.